WAM
INBS icon

Warberg Asset Management’s Intelligent Bio Solutions INBS Stock Holding History

Warberg Asset Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,469
Closed -$45.6K – 198
2025
Q3 		$45.6K Buy
+4,469
New +$72K 0.01% 153

Other funds holding INBS

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $322M AUM 16.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Warberg Asset Management's INBS Position: Q4 2025 in Review

Warberg Asset Management sold out of Intelligent Bio Solutions (INBS) in Q4 2025, closing a stake of 4,469 shares — an estimated $45.6K sold.

Warberg Asset Management first reported a position in INBS in Q3 2025 and held it in 1 quarter. The position peaked at $45.6K in Q3 2025. 7 funds tracked by Wall St. Rank hold INBS as of Q4 2025.

  • Warberg Asset Management reported no remaining Intelligent Bio Solutions position as of Q4 2025 after selling out during the quarter.
  • Warberg Asset Management sold 4,469 Intelligent Bio Solutions shares in Q4 2025, an estimated $45.6K.
  • Warberg Asset Management first reported a position in Intelligent Bio Solutions in Q3 2025 and held it in 1 quarter.
  • Warberg Asset Management's Intelligent Bio Solutions position peaked at $45.6K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2025.

Based on Warberg Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.